Form D · Pharmaceuticals
CURAXIS PHARMACEUTICAL Corp
Alpharetta, 2Q · CIK 0001170723
Offering snapshot reported Feb 18, 2010 · SEC filing
- Reported sold
- $1.53M Offering amount: $1.53M
- Investors reported
- 72 Form D · investor count
- Minimum accepted
- $2K Reported outside-investor minimum
- First sale
- Feb 5, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 18, 2010 | Initial | $1,526,000 | No comparison | 72 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-42025
Source: Form D, filed Feb 18, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David J Corcoran | Director, Executive |
| Judy Geaslen | Executive |
| Sheldon L Goldberg | Director |
| William Edward Mc Conville | Director |
| Ronald Pompeo | Director |
| Patrick S Smith | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
12600 Deerfield Parkway Suite 100
Alpharetta, 2Q, 30004
Alpharetta, 2Q, 30004